Skip to main content
. Author manuscript; available in PMC: 2009 Sep 11.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2008;48:463–493. doi: 10.1146/annurev.pharmtox.48.113006.094615

Table 3.

Characteristics of Kidney injury molecule-1 (Kim-1)*

Parameters Description
Other names Hepatitis A virus cellular receptor-1 (HAVCR-1), T cell immunoglobulin like molecule-1 (TIM-1), cochlear injury molecule-1 (CIM-1)
Chromosomal location Human (5q31), chimpanzee (5), rat (10q21), mouse (11B1.1)
Molecular mass Human (359 aa), chimpanzee (predicted: 357 aa), rat (307 aa), mouse (305 aa)
Structure Immunoglobulin domain, threonine-serine-proline-rich mucin domain, transmembrane domain, short cytoplasmic tail
Number of KIM-1 homologues Human (three: KIM-1, KIM-3, KIM-4), rat (six: Kim-1 to Kim-6), mouse (eight: Kim-1 to Kim-8)
% Identity of human KIM-1 protein Chimpanzee (79%), rat (39%), mouse (37%)
Upregulation in kidney injury/toxicity/dedifferentiation models Adriamycin-nephrosis Ischemia/reperfusion
Brain dead donor rat kidney Kidney fibrosis
Cadmium Mercuric chloride
Chromium Ochratoxin
Cisplatin Polycystic kidney disease
Cyclosporine Protein-overload
Endotoxin Renal cell carcinoma
Folic acid Sevoflurane
Gentamicin S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFEC)
*

Adapted and modified from Vaidya and Bonventre, 2006 (27).